Newsroom
Sorted by: Latest
-
Triple-I/Milliman: US P/C Insurance Industry Navigates Recovery Following Years of Elevated Claims Costs and Economic Disruption
MALVERN, Pa.--(BUSINESS WIRE)--The U.S. property/casualty (P/C) insurance industry showed improving underwriting conditions in 2025, according to Triple-I and Milliman....
-
UK EdTech Platform Edumentors Crosses $4 Million in Sales With 1.8x Growth — Yazan Al Homsi-Backed Company Deploys Four AI Tools Across Tutoring Marketplace
DUBAI, UAE--(BUSINESS WIRE)--Edumentors (edumentors.co.uk), an AI-enabled online tutoring marketplace connecting students with tutors from elite universities, including Cambridge and Oxford, has surpassed $4 million in cumulative sales and posted 1.8 times year-over-year revenue growth. The company has simultaneously launched four new AI-powered tools across its platform and completed the Malta EdTech Accelerator programme, marking a significant operational and commercial milestone in its growt...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: ORBITA FUNDING 2023-1 PLC GBP 326,642,000.00 MATURING: 22-Oct-2030 ISIN: XS2699151028 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Apr-2026 TO 22-May-2026 HAS BEEN FIXED AT 4.59 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 22-May-2026 WILL AMOUNT TO: GBP 594,740.20 PER GBP 157,808,776.46 DENOMINATION ...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Macquarie Bank Ltd Australia. USD 30,000,000.00 MATURING: 23-Feb-2032 ISIN: XS2446807633 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Feb-2026 TO 22-May-2026 HAS BEEN FIXED AT 4.56 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 22-May-2026 WILL AMOUNT TO: USD 334,496.80 PER USD 30,000,000.00 DENOMINATION ...
-
Oatley Vigmond Named One of Canada's Top Personal Injury Boutiques
TORONTO--(BUSINESS WIRE)--Oatley Vigmond LLP has once again been recognized by Canadian Lawyer as one of Canada’s Top Personal Injury Boutiques, reinforcing the firm’s longstanding reputation for catastrophic injury litigation, trial advocacy, and client representation across Ontario. Oatley Vigmond has earned this distinction every year since Canadian Lawyer first published the ranking in 2011, marking 15 consecutive years of recognition among Canada’s leading personal injury law firms. The an...
-
Taco Bueno Launches Drone Delivery in North Texas
DALLAS--(BUSINESS WIRE)--Zipline and Taco Bueno launched drone delivery in North Texas, with plans to expand to more locations in 2026....
-
STARTEEPO Invest Announces 5% Stake in Xerox Holdings Corporation
PRAGUE--(BUSINESS WIRE)--STARTEEPO Invest (“STARTEEPO”), an alternative investment fund focused on public equity opportunities, today announced that it has acquired a significant ownership position in Xerox Holdings Corporation (“Xerox” or the “Company”). As of the date of this release, STARTEEPO and its affiliates beneficially owns 6.6 million shares of Xerox (excluding options), representing approximately 5.05% of the Company’s outstanding common stock. STARTEEPO has filed a Schedule 13D with...
-
AM Best Affirms Credit Ratings of Berkshire Hathaway Life Insurance Company of Nebraska and First Berkshire Hathaway Life Insurance Company
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa+” (Superior) of Berkshire Hathaway Life Insurance Company of Nebraska (BHLN) (Omaha, NE). In addition, AM Best has affirmed the FSR of A+ (Superior) and the Long-Term ICR of “aa-” (Superior) of First Berkshire Hathaway Life Insurance Company (First Berkshire Hathaway Life) (New York, NY). The outlook of these Credit Ratings (rat...
-
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that Week 24 and Week 48 results from the Phase 2 open-label HELIOS clinical trial of AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol, in adults living with Wolfram syndrome have been published in The Journal of Clinical Investigation, a peer-reviewed medical journal. The publication reports Week 24 and Week 48 results from the Phase 2 ope...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 5/14/2026 Issue ¦ Standard Chartered Bank - Series 271 USD 30,000,000 FRN due August 2026 ISIN Number ¦ XS2668508083 ISIN Reference ¦ 266850808 Issue Nomin USD ¦ 30000000 Period ¦ 2/23/2026 to 5/21/2026 Payment Date 5/21/2026 Number of Days ¦ 87 Rate ¦ 4.76208 Denomination USD ¦ 1000 ¦ 30000000 ¦ Amount Payable per Denomination ¦ 11.51 ¦ 345300 ¦ Bank of New York Rate...